Cancer Research AACR Conference on Molecular Diagnostics - 2008  AACR Conference on Molecular Diagnostics - 2008
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 31, 114-121, February 1, 1971]
© 1971 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Miura, M.
Right arrow Articles by Yamada, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Miura, M.
Right arrow Articles by Yamada, K.

Influence of L-Asparaginase on Antibody Production and Growth of Tumors in Allogeneic Mice

Moriji Miura, Kohei Kawashima, Tadaaki Uetani, Masami Hirano, Hisami Kakizawa, Ryuzo Ohno, Akimitsu Morita, Hiroshi Nishiwaki and Kazumasa Yamada

First Department of Internal Medicine, Nagoya University School of Medicine, 65, Tsurumai-cho, Showa-ku, Nagoya, Japan

The effect of L-asparaginase on immunosuppression in mice was studied with procedures measuring the ability to produce circulating antibodies against sheep erythrocytes and allogeneic tumor cells and the incidence of tumor take in the allogeneic mice. The production of anti-sheep erythocyte antibodies on primary immune response in C57BL/Na x A/Jax F1 mice was markedly suppressed at a dose of 25 i.u. of L-asparaginase/mouse, and the degree of the immunosupression was just parallel to the dose of enzyme administered. On the contrary, the enzyme failed to suppress the secondary immune response to sheep erythrocytes. The production of cytotoxic antibody in mice bearing allogeneic tumors was also depressed by the enzyme treatment; however, the duration of the immunosuppression was temporary. Successful tumor allograft was observed with enzyme treatment in the systems of C57BL/Na versus L1210 and CBA/Na versus EL4. The minimum effective dose for allogeneic tumor take was 1000 i.u. of L-asparaginase/mouse for a system of C57BL/Na versus L1210 and 200 i.u. for a system of CBA/Na versus EL4. Tumor allograft in a system of C57BL/Na versus 6C3HED-OG or -RG was regressed at a dose of 800 to 1000 i.u. of L-asparaginase. Histological findings revealed that the cells associated with immune reactions were scarce in the tumor-grafted area and ascites of the enzyme-treated mice, as compared to those of the 0.9% NaCl solution-treated mice. These results indicate that L-asparaginase acts as one of the potent immunosuppressive agents. The mechanisms of immunosuppression by the enzyme are discussed.

Received 7/23/69. Accepted 9/25/70.




This article has been cited by other articles:


Home page
ScienceHome page
H. Friedman
L-Asparaginase Induced Immunosuppression: Inhibition of Bone Marrow Derived Antibody Precursor Cells
Science, October 8, 1971; 174(4005): 139 - 141.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1971 by the American Association for Cancer Research.